MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202411003334 A) filed by Dr. Krishna Srivastava; Dr. Nitin Srivastava; Dr. Rishi Kumar Vishnoi; Dr. Braj Kishore Rathour; Dr. Soniya Singh; and Dr. Manoj Kumar Verma, Barabanki, Uttar Pradesh, on Jan. 15, 2024, for 'a novel heterocyclic compounds involving oxazine and chalcone and method of synthesis thereof.'
Inventor(s) include Dr. Krishna Srivastava; Dr. Nitin Srivastava; Dr. Rishi Kumar Vishnoi; Dr. Braj Kishore Rathour; Dr. Soniya Singh; and Dr. Manoj Kumar Verma.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The invention provides a novel heterocyclic compound (1H-benzo[d]imidazol-2-yl) (3-(3- (4-chlorophenyl)-3,4-dihydro-2H-benzo[e] [1,3] oxazin-7-yl) oxiran-2-yl) methanone. The invention also provides a cost-effective and modified method of synthesis for obtaining novel heterocyclic compound (1H-benzo[d]imidazol-2-yl) (3-(3-(4-chlorophenyl)-3,4- dihydro-2H-benzo[e] [1,3] oxazin-7-yl) oxiran-2-yl) methanone."
Disclaimer: Curated by HT Syndication.
